Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc.

Biotechnology Research Purchase, New York, United States 41 employees
Employees
41
Contacts
4
Emails
4
Phones
3

Cognition Therapeutics, Inc. Overview

Headquarters
Purchase, New York, United States
Phone Number
Available in AeroLeads
Website
cogrx.com
Industry
Biotechnology Research
Employees
41
Founded
2007
Funding
11.5M
Company Email
Available in AeroLeads
NAICS
Research and Development in Biotechnology (except Nanobiotechnology)

About Cognition Therapeutics, Inc.

Cognition Therapeutics, Inc. is a clinical stage company developing oral drugs for neurodegenerative disorders like Alzheimer's disease and dementia with Lewy bodies.

Cognition Therapeutics, Inc. Contact Details

People in AeroLeads
4
With contact data
4
Email contacts
4
100.0% coverage
Phone contacts
3
75.0% coverage

Cognition Therapeutics, Inc. Org Chart

Sample employees and titles
Name Title Contact
Steven A. Weissman Vice President, Head of Cmc at Cognition Therapeutics
Email
Amanda Carber
Email Phone
Jennifer Iaci Vice President of Development Operations
Email Phone
Gilbert M. Rishton Cso at Cardax / Co-founder and Chief Chemistry Advisor at Cognition Therapeutics / Drug Development, Los Angeles
Email Phone

Employees by Management Level

Individual contributor 4 profiles
Executive 3 profiles
Associate / junior 1 profile

Department Contact Coverage

Department Contacts Email Phone
General 2 2 1
Healthcare 1 1 0

Compare Similar Companies to Cognition Therapeutics, Inc.